In this episode of All-In with Chamath, Jason, Sacks & Friedberg, Daniel Ek discusses his post-Spotify venture, Neco Health, which aims to make comprehensive preventative healthcare accessible through annual $499 diagnostic checkups. Ek explains how Neco uses vertical integration and AI-assisted diagnostics to deliver profitable healthcare screenings, following the same local validation strategy that made Spotify successful. The conversation explores fundamental problems with U.S. healthcare, including misaligned incentives that favor reactive treatment over prevention and system dysfunction despite massive spending.
Beyond healthcare, Ek reflects on AI's transformative potential in both medicine and music curation, while cautioning against overconfident regulation. He also shares insights from Spotify's journey—from solving music piracy through legal streaming to navigating complex label negotiations—and discusses his entrepreneurial philosophy. Throughout, Ek emphasizes his preference for building and actively managing companies over passive investing, explaining how early experiences and long-held convictions about systemic problems shaped both Spotify and Neco.

Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
Neco Health delivers comprehensive preventative healthcare diagnostics for $499 annually. The company owns every component—facilities, staff, equipment, and software—creating a streamlined experience that typically lasts about an hour. A typical visit includes blood analysis of 53 markers, skin scans capturing over 6,000 images, cardiovascular assessments, and dedicated clinician time to review results and provide health advice.
Neco's data from over 100,000 scans in Sweden and the UK shows that 1% of members have serious undiagnosed conditions, while healthy members receive guidance on lifestyle improvements around stress, diet, and sleep. The ability to track health metrics annually encourages positive behavioral changes.
Founded in 2018, Neco spent five years developing its product in Sweden before launching in the UK in 2023. Following Spotify's strategy of local validation before expansion, Neco has now opened its first New York clinic and plans rapid nationwide growth within 12 to 24 months.
By owning all core diagnostic tools and infrastructure, Neco dramatically reduces operating costs while maintaining quality. This vertical integration makes clinics profitable at the $499 price point, allowing the company to deliver exceptional value while investing in growth.
Neco uses AI to flag potential risk factors, which are then reviewed by clinicians for accuracy. The company also leverages longitudinal data, cataloging every mole and result to enable year-over-year tracking that detects subtle developments human doctors might miss.
Neco encourages annual checkups similar to dental visits, making comprehensive health screening feasible even for busy individuals. The company envisions that routine participation could represent 2% to 4% of U.S. healthcare spending, potentially transforming prevention costs and dramatically improving national healthcare outcomes.
Daniel Ek explains that the U.S. healthcare system is structured around acute care rather than prevention. Because most healthcare is employment-based and the average person stays with an employer for only two to three years, insurers view long-term preventative investments as economically irrational. Providers are unlikely to benefit from cost savings achieved ten or twenty years in the future.
Ek emphasizes that shifting toward preventative care requires structural incentive changes. He and his co-founder Yalmar believe the solution begins with better data—predictive, multimodal, and longitudinal datasets that can identify adverse outcomes early and justify long-term investment. By reducing per-person preventative assessment costs, it becomes feasible to seek positive returns even with 10-to-20 year payback periods.
Despite the United States spending 18% of its GDP on healthcare, outcomes lag significantly. Ek notes that heart disease alone accounts for hundreds of billions of dollars annually. David Friedberg highlights system dysfunction by citing extreme cost variations—$15,000 for emergency room stitches, $20,000 for a $30 drug—underscoring fundamental misalignments between investment and actual health outcomes.
Neco publishes anonymized health data annually from multiple countries, revealing population health differences. For example, Sweden's population is typically more fit, while the UK exhibits higher rates of cardiovascular disease and diabetes. These insights, shared through partnerships with research institutions, help identify best practices and highlight areas needing reform across different national systems.
Daniel Ek illustrates AI's transformative effect by noting that the average person has around 950 moles, which poses a significant tracking challenge for doctors. AI-assisted tools enable comprehensive monitoring far beyond human capacity, detecting abnormal growth patterns and potential disease developments much earlier and more efficiently.
Ek describes how AI has revolutionized music curation, producing playlists that can match or surpass human capability. He highlights how music amplifies emotions—if someone is happy, music heightens that happiness—and AI personalization leverages these emotional responses to create impactful listening experiences.
Ek reflects on recent global events where experts demonstrated strong confidence in matters they ultimately misunderstood. He warns that the same overconfidence threatens AI regulation, advocating for humility rather than pursuing speculative or static regulations based on uncertain predictions of harm.
Ek and Friedberg discuss how open and closed models will continue side by side, each offering distinct value. Open models drive accessibility and lower costs—enabling token processing at $0.13 per million compared to $30 for closed models. Proprietary models enable deeper optimization for cost and efficiency, achieving performance otherwise unattainable.
Friedberg and Ek argue that the real limiting factor for potentially dangerous AI uses is computational power required. Running powerful models at scale with 100,000 GPUs far surpasses what individuals could do at home. They suggest that compute availability—tracked through metrics like data center wattage or GPU counts—should be treated as an enforceable guardrail, providing a practical and adaptable regulatory approach.
When Spotify was founded, music piracy dominated global markets, with Sweden's music industry losing about 80% of its revenue to file-sharing platforms. This pre-smartphone era experienced huge unmet demand for accessible music, but legal streaming choices were nonexistent in many markets.
Daniel Ek and his partner invested their own money to convince skeptical record labels to license their catalogs. They guaranteed labels would match last year's bonuses and budgets, eliminating risk if Spotify failed. This novel structure, after several years of negotiation, led to Spotify's launch in Sweden in late 2008.
Spotify chose Sweden as its initial launchpad because of fast broadband, high digital adoption, and an entrenched piracy culture. The company proved its value there, then expanded to the UK before entering the U.S. in 2011—15 years after its founding—a rare display of patience.
Spotify solved piracy's core problem by offering instant access to global music content that was both legal and convenient, compensating artists while catering to listener demand. Over two decades, Spotify has grown to more than 700 million active users and 300 million premium subscribers, transforming how the world experiences music.
Daniel Ek underscores that prior to Spotify's 2018 public listing, he lacked both resources and inclination for angel investing. Even when the IPO gave him capacity to invest, his entrepreneurial drive remained aligned with building and actively managing companies. Ek notes that mismanagement by others often frustrates hands-on builders, complicating passive investment.
Currently, Ek acts as Executive Chairman at Spotify, with two CEOs handling daily operations. At Neco, he credits co-founder Jelmer as "the real brain" of the operation, with Ek providing capital, knowledge, and strategic guidance without direct operational responsibility.
Ek launched Prima Materia with partner Shaq to serve as an active venture vehicle, aiming to be the "greatest co-founder you could possibly find." Rather than passive investing, Prima Materia provides capital, deep expertise, and strategic partnership, focusing on transformative companies with exceptional founder-market fit.
Before Spotify, Ek worked on Stardoll, where he addressed major technical challenges like reducing four-minute load times by rearchitecting server infrastructure. Rebuilding Stardoll's infrastructure and assembling effective teams validated core principles around recruitment, organizational structure, and operational rigor that became foundational to Spotify's success.
Ek's interest in healthcare began around 2012 or 2013, when he identified inefficiencies in healthcare—specifically how costs rise while outcomes deteriorate. Despite no immediate entrepreneurial opportunity, this conviction motivated early exploration, ultimately leading to Neco's founding in 2018. His career reflects a commitment to pursuing large, systemic problems and long-term transformation over quick financial returns.
1-Page Summary
Neco Health delivers a reinvented, vertically integrated healthcare experience for preventative diagnostics. For a $499 annual service fee, Neco manages every component: it builds and operates its own facilities, employs its own nurses and doctors, and designs proprietary diagnostic equipment and software. This creates an end-to-end experience where patients move efficiently through a streamlined, tech-enabled process.
During a typical Neco visit, the process begins with a blood draw for analysis of 53 markers. Next, a skin scan captures over 6,000 high-resolution images, indexing every mole, lesion, and abnormality. Cardiovascular health and grip strength are assessed, alongside other traditional health indicators with proven scientific value. Patients conclude their visit with uninterrupted clinician time to review all results, explore questions, and receive advice for improving their health. The full experience generally lasts about an hour, but results-focused visits can be completed in 30-40 minutes.
Neco’s results in Sweden and the UK, with over 100,000 scans delivered, show that about 1% of members have serious but previously undiagnosed medical conditions, while healthy members gain advice on lifestyle improvements—most often around stress, diet, and sleep. Their annual data surveys highlight that individuals with the worst initial health statuses typically see the greatest improvements, and the ability to visualize and track health metrics yearly encourages positive changes such as quitting smoking or adopting healthier habits.
Founded in 2018, Neco spent five years developing and iterating its product in Sweden before launching in the UK in 2023 to validate further. Its strategy mirrors the playbook of Spotify, which involves focusing on success in a local market and then expanding internationally. Now Neco is live in New York, opening its first clinic at 300 Lafayette, with rapid expansion plans for Miami, Washington D.C., and nationwide within 12 to 24 months.
By owning all core diagnostic tools and infrastructure, Neco dramatically reduces operating costs while ensuring service quality. This vertical integration makes clinics profitable even at the $499 price point, allowing Neco to deliver exceptional value to patients and invest for growth. As the company rolls out its Generation 2 diagnostics, it plans to introduce new capabilities that enhance value without raising prices, supporting scalable expansion.
Neco uses AI to flag potential risk factors in diagnostic data; these are then reviewed by a clinician for accuracy. If f ...
Neco's Healthcare Innovation: Launch, Business Model, Diagnostics, Health Checkups
The U.S. healthcare system is historically designed around infectious disease and acute care, with incentives structured to address symptoms only when they become severe. Daniel Ek explains that these incentives encourage the system to focus on fixing people acutely rather than supporting preventative care and long-term health. One root problem is that most U.S. healthcare is tied to employment. Because the average person remains with a single employer—and thus a single insurer—for only two to three years, providers view long-term investments in preventative health as economically irrational. Making long-term, preventative investments loses appeal when insurers are unlikely to benefit from the cost savings achieved ten or twenty years in the future. Employers and insurers face speculative investments with uncertain long-term returns, and sparse longitudinal data makes the case for such spending hard to quantify and justify.
Daniel Ek emphasizes that shifting toward a preventative care model requires structural changes in incentives. Most in the healthcare sector agree on the need to move away from reactive care, but there is less consensus on how to actually accomplish this. Ek and his co-founder Yalmar believe the solution begins with better data: predictive, multimodal, and longitudinal datasets can identify adverse outcomes early and justify long-term investment. By reducing the per-person cost of preventative assessment from millions of dollars to tens of thousands, it becomes feasible to seek a positive return on investment even with a 10-to-20 year payback period. Larger datasets more clearly show efficacy of preventative programs over time, further building the business case and encouraging market adoption.
Despite spiraling costs and increased spending, U.S. healthcare outcomes lag and costs remain deeply misaligned with value delivered. Ek notes that the United States spends 18% of its GDP on healthcare, making it the single largest budget line item. Heart disease alone accounts for hundreds of billions of dollars annually—outpacing the revenues of Fortune 10 companies. David Friedberg highlights system dysfunction by citing extreme cost variations: $15,000 for emergency room stitches, $20,000 for a drug that costs $30 to make, and $6,000 insurance charges for an eight-minute doctor visit, even though the physician’s annual salary is $200,000. T ...
Healthcare System Issues: Cost, Incentives, and Preventative Care Shift
Daniel Ek illustrates AI’s transformative effect on healthcare by referencing dermatology. He notes that the average person may have around 950 moles, which poses a significant challenge for any doctor to track over time. AI-assisted tools enable comprehensive monitoring of all these moles, providing a level of scale, precision, and memory far beyond human capacity. By indexing sorted image data over many years, AI systems can detect abnormal growth patterns and potential disease developments much earlier and more efficiently than human doctors, ensuring significantly better preventative care.
Ek describes how AI has revolutionized music curation and personalization. He observes that AI-driven playlist curation can now match or surpass human capability, producing superior playlists to suit individual moods and circumstances. In the future, AI could potentially soundtrack every moment of daily life, further integrating music into human experience. Ek highlights the emotional amplification that music provides—if someone is happy, music can heighten that happiness; if someone is sad, music can deepen that feeling. AI personalization leverages these emotional responses for a compound benefit, tailoring selections to create impactful listening experiences.
Ek reflects on recent global events—COVID-19, supply chain shocks, and military conflicts—where both the general public and many experts demonstrated strong confidence in matters they ultimately misunderstood. He warns that the same overconfidence threatens to shape AI regulation. Rather than pursuing speculative or static regulations based on uncertain predictions of harm, Ek advocates for humility, recognizing that most expert predictions have proven wrong. He urges society to focus on thoughtfully guiding the current wave of technological development, emphasizing that choices about how AI is deployed are more important and actionable than any once-and-for-all set of regulatory rules.
Ek and Friedberg discuss the recurring pattern in technology markets, where open and closed models coexist. Using examples like Windows versus Linux and iOS versus Android, they anticipate that both open-source and proprietary AI models will continue side by side, each offering distinct value. Open models drive diffusion, accessibility, and lower costs—for instance, enabling token processing at $0.13 per million compared to $30 for closed models. Proprietary models, as used by Spotify, enable deeper optimization for cost, efficiency, and fine-tuning specific to platform needs, achieving performance otherwise unattainable. Ek emphasizes that both approaches power innovation and specializ ...
Ai In Healthcare and Music: Benefits, Regulations, Open vs. Closed Models
Spotify’s rise to become a global streaming powerhouse results from innovative problem-solving and persistence in the face of industry skepticism. Led by co-founder Daniel Ek, the company followed a long-term vision for transforming music listening in a time dominated by piracy and a lack of legal alternatives.
During the era when Spotify was founded, music piracy dominated global markets. Sweden’s music industry alone had lost about 80% of its revenue to file-sharing platforms like Napster and Kazaa. The U.S. industry, beset by similar challenges, responded by having the RIAA sue individual consumers for illegal downloads, but these actions did little to roll back mass adoption of piracy. This pre-smartphone era experienced huge unmet demand for accessible music, but legal streaming choices were nonexistent, especially in markets like Sweden where iTunes had not yet launched. Most people, with access to fast broadband and no legal options, simply pirated music.
Daniel Ek and his partner invested their own money to convince skeptical record labels to license their catalogs for Spotify. They guaranteed the labels that they would match last year's bonuses and budgets, ensuring labels wouldn't lose if Spotify failed. If things didn’t work out, the labels could shut down the partnership after a year risk-free, and if it did, everyone benefited. This novel structure eliminated risk for the industry while promising reward, which—after several years of negotiation—led to Spotify's launch in Sweden in late 2008. User response instantly validated the streaming model.
Spotify chose Sweden as the initial launchpad because of its unique conditions: fast broadband, high digital adoption, and an entrenched piracy culture. The company proved its value by succeeding in this challenging market, then expanded to the UK, where it became another major hit. It took another stepwise approach rather than an immediate international launch, using resu ...
Spotify's Journey: From Building the Service To U.S. Launch
Daniel Ek’s entrepreneurial journey demonstrates a deep commitment to building companies, a careful approach to investing, and a lasting influence from prior ventures that shape his management style and philosophy.
Daniel Ek underscores that, prior to Spotify’s public listing in 2018, he lacked both the resources and inclination for angel investing. His focus was “all in” on building Spotify for more than a decade. Even when the IPO gave him the capacity to invest, he found that his entrepreneurial drive remained aligned with building and actively managing companies rather than passive portfolio investing. Ek notes that mismanagement by others often frustrates hands-on builders, and this tension complicates being a passive investor, regardless of financial returns.
Spotify’s IPO in 2018 marked a financial turning point. While this enabled Ek to begin some angel investing, he admits his passion still lies in creating and scaling companies. His main motivation and satisfaction come from solving problems alongside a team, rather than passively investing in other founders’ ventures.
Currently, Daniel Ek acts as Executive Chairman at Spotify, stepping away from daily operational duties and focusing more on broader strategic direction. Spotify now operates under two CEOs, reflecting a significant evolution from Ek’s earlier, more hands-on leadership style.
At his healthcare venture Neco, Ek again avoids direct operational management. He credits his co-founder Jelmer as “the real brain” of the operation, with Jelmer driving day-to-day work while Ek provides capital, knowledge, and strategic guidance. This structure allows Ek to influence company trajectory without the responsibilities of hands-on management.
Ek launched Prima Materia with partner Shaq to serve as an active venture vehicle, aiming to be the “greatest co-founder you could possibly find.” Rather than merely backing ventures as a passive investor, Prima Materia’s ambition is to provide not only capital but also deep expertise and strategic partnership. The focus is on identifying and supporting transformative companies with exceptional founder-market fit.
Before Spotify, Ek worked on Stardoll, where he was responsible for addressing major technical and operational challenges—such as reducing four-minute load times ...
Entrepreneurial Philosophy: Balancing Building, Investing, Managing Ventures, and Founding Lessons
Download the Shortform Chrome extension for your browser
